ReP USP - Resultado da busca

Artigo de periodico
Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia (2015)
Rabello, Doralina do Amaral; Lucena-Araujo, Antonio Roberto; Silva, Juliana Carvalho Rocha Alves; Eira, Vinícius Burnett Aboud Souza da; Vasconcellos, Maria Catarina Cals de; Oliveira, Fábio Morato de; Rego, Eduardo Magalhães; Araújo, Felipe Saldanha; Silva, Fábio Pittella
Source: Blood Cells, Molecules and Diseases. Unidade: FMRP
Subjects: EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, PROTEÍNAS QUINASES, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELLO, Doralina do Amaral et al. Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia. Blood Cells, Molecules and Diseases, v. 54, n. 1, p. 97-102, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.07.013. Acesso em: 06 nov. 2024.
APA
Rabello, D. do A., Lucena-Araujo, A. R., Silva, J. C. R. A., Eira, V. B. A. S. da, Vasconcellos, M. C. C. de, Oliveira, F. M. de, et al. (2015). Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia. Blood Cells, Molecules and Diseases, 54( 1), 97-102. doi:10.1016/j.bcmd.2014.07.013
NLM
Rabello D do A, Lucena-Araujo AR, Silva JCRA, Eira VBAS da, Vasconcellos MCC de, Oliveira FM de, Rego EM, Araújo FS, Silva FP. Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 54( 1): 97-102.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.07.013
Vancouver
Rabello D do A, Lucena-Araujo AR, Silva JCRA, Eira VBAS da, Vasconcellos MCC de, Oliveira FM de, Rego EM, Araújo FS, Silva FP. Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 54( 1): 97-102.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.07.013
Artigo de periodico
CALR mutations screening in wild type `JAK2 POT. V617F´ and `MPL POT. W515K/L´ Brazilian myeloproliferative neoplasm patients (2015)
Nunes, Daniela Prudente teixeira; Lima, Luciene Terezina de; Chauffaille, Maria de Lourdes; Mitne Neto, Miguel; Santos, Marcos Tadeu dos; Cliquet, Marcelo Gil; Guerra-Shinohara, Elvira Maria
Source: Blood Cells, Molecules and Diseases. Unidade: FCF
Subjects: MUTAÇÃO, EXPRESSÃO GÊNICA, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Daniela Prudente teixeira et al. CALR mutations screening in wild type `JAK2 POT. V617F´ and `MPL POT. W515K/L´ Brazilian myeloproliferative neoplasm patients. Blood Cells, Molecules and Diseases, v. 55, n. 3, p. 236-240, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2015.07.005. Acesso em: 06 nov. 2024.
APA
Nunes, D. P. teixeira, Lima, L. T. de, Chauffaille, M. de L., Mitne Neto, M., Santos, M. T. dos, Cliquet, M. G., & Guerra-Shinohara, E. M. (2015). CALR mutations screening in wild type `JAK2 POT. V617F´ and `MPL POT. W515K/L´ Brazilian myeloproliferative neoplasm patients. Blood Cells, Molecules and Diseases, 55( 3), 236-240. doi:10.1016/j.bcmd.2015.07.005
NLM
Nunes DP teixeira, Lima LT de, Chauffaille M de L, Mitne Neto M, Santos MT dos, Cliquet MG, Guerra-Shinohara EM. CALR mutations screening in wild type `JAK2 POT. V617F´ and `MPL POT. W515K/L´ Brazilian myeloproliferative neoplasm patients [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 55( 3): 236-240.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2015.07.005
Vancouver
Nunes DP teixeira, Lima LT de, Chauffaille M de L, Mitne Neto M, Santos MT dos, Cliquet MG, Guerra-Shinohara EM. CALR mutations screening in wild type `JAK2 POT. V617F´ and `MPL POT. W515K/L´ Brazilian myeloproliferative neoplasm patients [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 55( 3): 236-240.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2015.07.005
Artigo de periodico
ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance (2014)
Ferreira, A. F.; Moura, L. G.; Tojal, I.; Ambrósio, L.; Simões, Belinda Pinto; Hamerschlak, N.; Calin, G. A.; Ivan, C.; Covas, Dimas Tadeu; Kashima, Simone; Castro, Fabíola Attié de
Source: Blood Cells, Molecules and Diseases. Unidades: FMRP, FCFRP
Subjects: LEUCEMIA MIELOIDE AGUDA, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, v. 53, n. 1-2, p. 47-55, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.02.008. Acesso em: 06 nov. 2024.
APA
Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Simões, B. P., Hamerschlak, N., et al. (2014). ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, 53( 1-2), 47-55. doi:10.1016/j.bcmd.2014.02.008
NLM
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008
Vancouver
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation